The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - a post-hoc exploratory analysis of the randomized NORDIC9-study

Gabor Liposits; Jesper Ryg; Stine Braendegaard Winther; H. Skuladottir; Sören Möller; Eva Hofsli; C Shah; L. Poulsen; Ida Berglund; C. Qvortrup; Pia Osterlund; Bengt Glimelius; Halfdan Sorbye; Per Pfeiffer

doi:10.1016/j.annonc.2023.04.505

The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - a post-hoc exploratory analysis of the randomized NORDIC9-study

Gabor Liposits, Jesper Ryg, Stine Braendegaard Winther, H. Skuladottir, Sören Möller, Eva Hofsli, C Shah, L. Poulsen, Ida Berglund, C. Qvortrup, Pia Osterlund, Bengt Glimelius, Halfdan Sorbye, Per Pfeiffer

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

22 Downloads (Pure)

Original language	English
Article number	SO-33
Journal	Annals of Oncology
Volume	34
Issue number	Suppl. 1
Pages (from-to)	176-177
ISSN	0923-7534
DOIs	https://doi.org/10.1016/j.annonc.2023.04.505
Publication status	Published - 27. Jun 2023
Event	World Congress on Gastrointestinal Cancer 2023: ESMO GI - Barcelona Duration: 28. Jun 2023 → 1. Jul 2023

Conference

Conference	World Congress on Gastrointestinal Cancer 2023
City	Barcelona
Period	28/06/2023 → 01/07/2023

Documents & Links

10.1016/j.annonc.2023.04.505

NORDIC9_ESMOGI_2023Final published version, 110 KBLicence: Unspecified

Cite this

Liposits, G., Ryg, J., Winther, S. B., Skuladottir, H., Möller, S., Hofsli, E., Shah, C., Poulsen, L., Berglund, I., Qvortrup, C., Osterlund, P., Glimelius, B., Sorbye, H., & Pfeiffer, P. (2023). The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - a post-hoc exploratory analysis of the randomized NORDIC9-study. Annals of Oncology, 34(Suppl. 1), 176-177. Article SO-33. https://doi.org/10.1016/j.annonc.2023.04.505

@article{777b2903ec8d454694fa8994eb98f042,

title = "The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - a post-hoc exploratory analysis of the randomized NORDIC9-study",

author = "Gabor Liposits and Jesper Ryg and Winther, {Stine Braendegaard} and H. Skuladottir and S{\"o}ren M{\"o}ller and Eva Hofsli and C Shah and L. Poulsen and Ida Berglund and C. Qvortrup and Pia Osterlund and Bengt Glimelius and Halfdan Sorbye and Per Pfeiffer",

year = "2023",

month = jun,

day = "27",

doi = "10.1016/j.annonc.2023.04.505",

language = "English",

volume = "34",

pages = "176--177",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Suppl. 1",

note = "World Congress on Gastrointestinal Cancer 2023 : ESMO GI, WCGIC 2023 ; Conference date: 28-06-2023 Through 01-07-2023",

}

Liposits, G, Ryg, J, Winther, SB, Skuladottir, H, Möller, S, Hofsli, E, Shah, C, Poulsen, L, Berglund, I, Qvortrup, C, Osterlund, P, Glimelius, B, Sorbye, H & Pfeiffer, P 2023, 'The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - a post-hoc exploratory analysis of the randomized NORDIC9-study', Annals of Oncology, vol. 34, no. Suppl. 1, SO-33, pp. 176-177. https://doi.org/10.1016/j.annonc.2023.04.505

The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - a post-hoc exploratory analysis of the randomized NORDIC9-study. / Liposits, Gabor; Ryg, Jesper; Winther, Stine Braendegaard et al.
In: Annals of Oncology, Vol. 34, No. Suppl. 1, SO-33, 27.06.2023, p. 176-177.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - a post-hoc exploratory analysis of the randomized NORDIC9-study

AU - Liposits, Gabor

AU - Ryg, Jesper

AU - Winther, Stine Braendegaard

AU - Skuladottir, H.

AU - Möller, Sören

AU - Hofsli, Eva

AU - Shah, C

AU - Poulsen, L.

AU - Berglund, Ida

AU - Qvortrup, C.

AU - Osterlund, Pia

AU - Glimelius, Bengt

AU - Sorbye, Halfdan

AU - Pfeiffer, Per

PY - 2023/6/27

Y1 - 2023/6/27

U2 - 10.1016/j.annonc.2023.04.505

DO - 10.1016/j.annonc.2023.04.505

M3 - Conference abstract in journal

SN - 0923-7534

VL - 34

SP - 176

EP - 177

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 1

M1 - SO-33

T2 - World Congress on Gastrointestinal Cancer 2023

Y2 - 28 June 2023 through 1 July 2023

ER -

Liposits G, Ryg J, Winther SB, Skuladottir H, Möller S, Hofsli E et al. The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - a post-hoc exploratory analysis of the randomized NORDIC9-study. Annals of Oncology. 2023 Jun 27;34(Suppl. 1):176-177. SO-33. doi: 10.1016/j.annonc.2023.04.505